The Prescription Drug Marketing Act of 1987 (PDMA) was signed into law by the President on April 12, 1988. The PDMA was enacted to ensure that drug products purchased by consumers are safe and effective, and to avoid the unacceptable risk to American consumers from counterfeit, adulterated, misbranded, sub-potent, or expired drugs. The legislation was necessary to increase safeguards in the drug distribution system to prevent the introduction and retail sale of substandard, ineffective, or counterfeit drugs. (www.fda.gov)
The Drug Quality and Security Act (DQSA), was enacted by Congress on November 27, 2013. Title II of DQSA, the Drug Supply Chain Security Act (DSCSA), outlines steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. This will enhance FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. The system will also improve detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers. Independent Pharmaceutical is compliant with the Drug Supply Chain Security Act (DQSA) Sec. 581(27) (A)-(G).
Independent Pharmaceutical fully supports this effort. Independent Pharmaceutical is in full compliance with all current Federal and State laws. We do not buy any pharmaceutical products that have not been manufactured by a licensed Generic manufacturing company that adheres to the guidelines of the FDA. Our inventory is received , maintained, picked and shipped from our warehouse using lot specific data.Independent Pharmaceutical provides a pedigree with every order shipped.
To reach an Independent Pharmaceutical sales professional call 1-888-258-5036